Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Lipoprotein‐Associated Phospholipase A2Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease, Journal of the American Heart Association, June 2016, Wolters Kluwer Health,
DOI: 10.1161/jaha.116.003407.
You can read the full text:
Contributors
The following have contributed to this page
